Vertex Pharmaceuticals took a confidence hit as Leerink Partners downgraded the stock from “strong-buy” to a mere “hold,” ...

Vertex, Inc. (VERX) kicks off 2025 strong with 12.9% revenue growth, strategic AI investments, and e-invoicing innovations.

Q1 2025 Management View CEO Reshma Kewalramani highlighted $2.77 billion in revenue for Q1 2025, reflecting 3% growth ...

With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).

There aren't a lot of people out there who can claim to know what's going on in Aaron Rodgers' head, but Davante Adams is probably one of the few who at least has an idea. The Rams receiver, who ...

The NICE-Vertex saga continued this month with Vertex’s CEO Jeffrey Leiden hinting at ‘new ideas’ to bring cystic fibrosis drug Orkambi to UK patients. Leiden said that he is to meet with ...

Mervyn Tan, managing director, investment, at venture capital firm Vertex Holdings, will join the group to assume the roles, effective Jun 1. Singh, 61, will take on an advisory role from Jun 1, ST ...

Google has introduced Gemini 2.5 Flash, an early-preview AI model accessible via the Gemini API through Google AI Studio and Vertex AI. This model builds upon the foundation of Gemini 2.0 Flash, ...

Listen to Story Reshma Kewalramani named in TIME magazine's 100 Most Influential People 2025 First woman to lead a major US biotech firm in 2020 Vertex got FDA approval for CRISPR-based therapy under ...

Immersive training devices from Vertex Solutions are destined for the U.S. Air Force for the Fighter Bomber Fundamentals program. [Courtesy: Vertex Solutions] Vertex Solutions, a small business ...